Europe Non Alcoholic Fatty Liver Disease Market Report 2017

Europe Non Alcoholic Fatty Liver Disease Market Report 2017

1 Non Alcoholic Fatty Liver Disease Overview

1.1 Product Overview and Scope of Non Alcoholic Fatty Liver Disease

1.2 Classification of Non Alcoholic Fatty Liver Disease

1.2.1 Insulin Sensitizers

1.2.2 Statins

1.2.3 Pentoxifylline

1.2.4 Others

1.3 Application of Non Alcoholic Fatty Liver Disease

1.3.1 Pediatric?

1.3.2 Adults

1.4 Non Alcoholic Fatty Liver Disease Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of Non Alcoholic Fatty Liver Disease (2012-2022)

1.5.1 Europe Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2022)

1.5.2 Europe Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)

2 Europe Non Alcoholic Fatty Liver Disease by Manufacturers, Type and Application

2.1 Europe Non Alcoholic Fatty Liver Disease Market Competition by Manufacturers

2.1.1 Europe Non Alcoholic Fatty Liver Disease Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Non Alcoholic Fatty Liver Disease Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Non Alcoholic Fatty Liver Disease (Volume and Value) by Type

2.2.1 Europe Non Alcoholic Fatty Liver Disease Sales and Market Share by Type (2012-2017)

2.2.2 Europe Non Alcoholic Fatty Liver Disease Revenue and Market Share by Type (2012-2017)

2.3 Europe Non Alcoholic Fatty Liver Disease (Volume and Value) by Countries

2.3.1 Europe Non Alcoholic Fatty Liver Disease Sales and Market Share by Countries (2012-2017)

2.3.2 Europe Non Alcoholic Fatty Liver Disease Revenue and Market Share by Countries (2012-2017)

2.4 Europe Non Alcoholic Fatty Liver Disease (Volume) by Application

3 Germany Non Alcoholic Fatty Liver Disease (Volume, Value and Sales Price)

3.1 Germany Non Alcoholic Fatty Liver Disease Sales and Value (2012-2017)

3.1.1 Germany Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

3.1.2 Germany Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

3.1.3 Germany Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

3.2 Germany Non Alcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

3.3 Germany Non Alcoholic Fatty Liver Disease Sales and Market Share by Type

3.4 Germany Non Alcoholic Fatty Liver Disease Sales and Market Share by Application

4 France Non Alcoholic Fatty Liver Disease (Volume, Value and Sales Price)

4.1 France Non Alcoholic Fatty Liver Disease Sales and Value (2012-2017)

4.1.1 France Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

4.1.2 France Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

4.1.4 France Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

4.2 France Non Alcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

4.3 France Non Alcoholic Fatty Liver Disease Sales and Market Share by Type

4.4 France Non Alcoholic Fatty Liver Disease Sales and Market Share by Application

5 UK Non Alcoholic Fatty Liver Disease (Volume, Value and Sales Price)

5.1 UK Non Alcoholic Fatty Liver Disease Sales and Value (2012-2017)

5.1.1 UK Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

5.1.2 UK Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

5.1.5 UK Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

5.2 UK Non Alcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

5.3 UK Non Alcoholic Fatty Liver Disease Sales and Market Share by Type

5.4 UK Non Alcoholic Fatty Liver Disease Sales and Market Share by Application

6 Russia Non Alcoholic Fatty Liver Disease (Volume, Value and Sales Price)

6.1 Russia Non Alcoholic Fatty Liver Disease Sales and Value (2012-2017)

6.1.1 Russia Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

6.1.2 Russia Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

6.1.6 Russia Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

6.2 Russia Non Alcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

6.3 Russia Non Alcoholic Fatty Liver Disease Sales and Market Share by Type

6.4 Russia Non Alcoholic Fatty Liver Disease Sales and Market Share by Application

7 Italy Non Alcoholic Fatty Liver Disease (Volume, Value and Sales Price)

7.1 Italy Non Alcoholic Fatty Liver Disease Sales and Value (2012-2017)

7.1.1 Italy Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

7.1.2 Italy Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

7.1.7 Italy Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

7.2 Italy Non Alcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

7.3 Italy Non Alcoholic Fatty Liver Disease Sales and Market Share by Type

7.4 Italy Non Alcoholic Fatty Liver Disease Sales and Market Share by Application

8 Spain Non Alcoholic Fatty Liver Disease (Volume, Value and Sales Price)

8.1 Spain Non Alcoholic Fatty Liver Disease Sales and Value (2012-2017)

8.1.1 Spain Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

8.1.2 Spain Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

8.1.8 Spain Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

8.2 Spain Non Alcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

8.3 Spain Non Alcoholic Fatty Liver Disease Sales and Market Share by Type

8.4 Spain Non Alcoholic Fatty Liver Disease Sales and Market Share by Application

9 Benelux Non Alcoholic Fatty Liver Disease (Volume, Value and Sales Price)

9.1 Benelux Non Alcoholic Fatty Liver Disease Sales and Value (2012-2017)

9.1.1 Benelux Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

9.1.2 Benelux Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

9.1.9 Benelux Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

9.2 Benelux Non Alcoholic Fatty Liver Disease Sales and Market Share by Manufacturers

9.3 Benelux Non Alcoholic Fatty Liver Disease Sales and Market Share by Type

9.4 Benelux Non Alcoholic Fatty Liver Disease Sales and Market Share by Application

10 Europe Non Alcoholic Fatty Liver Disease Manufacturers Analysis

10.1 Conatus Pharmaceuticals

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification

10.1.2.1 Insulin Sensitizers

10.1.2.2 Statins

10.1.3 Conatus Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Daewoong Pharmaceutical

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification

10.2.2.1 Insulin Sensitizers

10.2.2.2 Statins

10.2.3 Daewoong Pharmaceutical Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Galmed International

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification

10.3.2.1 Insulin Sensitizers

10.3.2.2 Statins

10.3.3 Galmed International Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Kyorin Pharmaceutical

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification

10.4.2.1 Insulin Sensitizers

10.4.2.2 Statins

10.4.3 Kyorin Pharmaceutical Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Metabolic Solutions Development

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification

10.5.2.1 Insulin Sensitizers

10.5.2.2 Statins

10.5.3 Metabolic Solutions Development Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 Novartis AG

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification

10.6.2.1 Insulin Sensitizers

10.6.2.2 Statins

10.6.3 Novartis AG Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 Phenex Pharmaceuticals

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification

10.7.2.1 Insulin Sensitizers

10.7.2.2 Statins

10.7.3 Phenex Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

10.8 Raptor Pharmaceuticals

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification

10.8.2.1 Insulin Sensitizers

10.8.2.2 Statins

10.8.3 Raptor Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

10.8.4 Main Business/Business Overview

10.9 TCM Biotech International

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification

10.9.2.1 Insulin Sensitizers

10.9.2.2 Statins

10.9.3 TCM Biotech International Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

10.9.4 Main Business/Business Overview

10.10 Tobira Therapeutics

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification

10.10.2.1 Insulin Sensitizers

10.10.2.2 Statins

10.10.3 Tobira Therapeutics Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

10.10.4 Main Business/Business Overview

10.11 Verva Pharmaceuticals

10.12 Zafgen

11 Non Alcoholic Fatty Liver Disease Manufacturing Cost Analysis

11.1 Non Alcoholic Fatty Liver Disease Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Non Alcoholic Fatty Liver Disease

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Non Alcoholic Fatty Liver Disease Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Non Alcoholic Fatty Liver Disease Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Non Alcoholic Fatty Liver Disease Market Forecast (2017-2022)

14.1 Germany Non Alcoholic Fatty Liver Disease Sales Forecast (2017-2022)

14.2 France Non Alcoholic Fatty Liver Disease Sales Forecast (2017-2022)

14.3 UK Non Alcoholic Fatty Liver Disease Sales Forecast (2017-2022)

14.4 Russia Non Alcoholic Fatty Liver Disease Sales Forecast (2017-2022)

14.5 Italy Non Alcoholic Fatty Liver Disease Sales Forecast (2017-2022)

14.6 Spain Non Alcoholic Fatty Liver Disease Sales Forecast (2017-2022)

14.7 Benelux Non Alcoholic Fatty Liver Disease Sales Forecast (2017-2022)

14.8 Europe Non Alcoholic Fatty Liver Disease Sales Forecast by Type (2017-2022)

14.9 Europe Non Alcoholic Fatty Liver Disease Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Non Alcoholic Fatty Liver Disease

Table Classification of Non Alcoholic Fatty Liver Disease

Figure Europe Sales Market Share of Non Alcoholic Fatty Liver Disease by Type in 2015

Figure Insulin Sensitizers Picture

Figure Statins Picture

Figure Pentoxifylline Picture

Figure Others Picture

Table Application of Non Alcoholic Fatty Liver Disease

Figure Europe Sales Market Share of Non Alcoholic Fatty Liver Disease by Application in 2015

Figure Pediatric? Examples

Figure Adults Examples

Figure Germany Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)

Figure France Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)

Figure UK Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)

Figure Russia Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)

Figure Italy Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)

Figure Spain Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)

Figure Benelux Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)

Figure Europe Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2022)

Figure Europe Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)

Table Europe Non Alcoholic Fatty Liver Disease Sales of Key Manufacturers (2015 and 2016)

Table Europe Non Alcoholic Fatty Liver Disease Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Non Alcoholic Fatty Liver Disease Sales Share by Manufacturers

Figure 2016 Non Alcoholic Fatty Liver Disease Sales Share by Manufacturers

Table Europe Non Alcoholic Fatty Liver Disease Revenue by Manufacturers (2015 and 2016)

Table Europe Non Alcoholic Fatty Liver Disease Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Non Alcoholic Fatty Liver Disease Revenue Share by Manufacturers

Table 2016 Europe Non Alcoholic Fatty Liver Disease Revenue Share by Manufacturers

Table Europe Non Alcoholic Fatty Liver Disease Sales and Market Share by Type (2012-2017)

Table Europe Non Alcoholic Fatty Liver Disease Sales Share by Type (2012-2017)

Figure Sales Market Share of Non Alcoholic Fatty Liver Disease by Type (2012-2017)

Figure Europe Non Alcoholic Fatty Liver Disease Sales Growth Rate by Type (2012-2017)

Table Europe Non Alcoholic Fatty Liver Disease Revenue and Market Share by Type (2012-2017)

Table Europe Non Alcoholic Fatty Liver Disease Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Non Alcoholic Fatty Liver Disease by Type (2012-2017)

Figure Europe Non Alcoholic Fatty Liver Disease Revenue Growth Rate by Type (2012-2017)

Table Europe Non Alcoholic Fatty Liver Disease Sales and Market Share by Countries (2012-2017)

Table Europe Non Alcoholic Fatty Liver Disease Sales Share by Countries (2012-2017)

Figure Sales Market Share of Non Alcoholic Fatty Liver Disease by Countries (2012-2017)

Table Europe Non Alcoholic Fatty Liver Disease Revenue and Market Share by Countries (2012-2017)

Table Europe Non Alcoholic Fatty Liver Disease Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Non Alcoholic Fatty Liver Disease by Countries (2012-2017)

Table Europe Non Alcoholic Fatty Liver Disease Sales and Market Share by Application (2012-2017)

Table Europe Non Alcoholic Fatty Liver Disease Sales Share by Application (2012-2017)

Figure Sales Market Share of Non Alcoholic Fatty Liver Disease by Application (2012-2017)

Figure Germany Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

Figure Germany Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

Figure Germany Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

Table Germany Non Alcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table Germany Non Alcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table Germany Non Alcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table Germany Non Alcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table Germany Non Alcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table Germany Non Alcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Figure France Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

Figure France Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

Figure France Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

Table France Non Alcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table France Non Alcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table France Non Alcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table France Non Alcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table France Non Alcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table France Non Alcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Figure UK Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

Figure UK Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

Figure UK Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

Table UK Non Alcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table UK Non Alcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table UK Non Alcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table UK Non Alcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table UK Non Alcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table UK Non Alcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Figure Russia Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

Figure Russia Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

Figure Russia Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

Table Russia Non Alcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table Russia Non Alcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table Russia Non Alcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table Russia Non Alcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table Russia Non Alcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table Russia Non Alcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Figure Italy Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

Figure Italy Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

Figure Italy Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

Table Italy Non Alcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table Italy Non Alcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table Italy Non Alcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table Italy Non Alcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table Italy Non Alcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table Italy Non Alcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Figure Spain Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

Figure Spain Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

Figure Spain Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

Table Spain Non Alcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table Spain Non Alcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table Spain Non Alcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table Spain Non Alcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table Spain Non Alcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table Spain Non Alcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Figure Benelux Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)

Figure Benelux Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)

Figure Benelux Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)

Table Benelux Non Alcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)

Table Benelux Non Alcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)

Table Benelux Non Alcoholic Fatty Liver Disease Sales by Type (2015 and 2016)

Table Benelux Non Alcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)

Table Benelux Non Alcoholic Fatty Liver Disease Sales by Application (2015 and 2016)

Table Benelux Non Alcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)

Table Non Alcoholic Fatty Liver Disease Basic Information List

Table Conatus Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Conatus Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales Market Share (2012-2017)

Table Daewoong Pharmaceutical Basic Information List

Table Daewoong Pharmaceutical Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

Table Daewoong Pharmaceutical Non Alcoholic Fatty Liver Disease Sales Market Share (2012-2017)

Table Galmed International Basic Information List

Table Galmed International Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

Table Galmed International Non Alcoholic Fatty Liver Disease Sales Market Share (2012-2017)

Table Kyorin Pharmaceutical Basic Information List

Table Kyorin Pharmaceutical Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

Table Kyorin Pharmaceutical Non Alcoholic Fatty Liver Disease Sales Market Share (2012-2017)

Table Metabolic Solutions Development Basic Information List

Table Metabolic Solutions Development Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

Table Metabolic Solutions Development Non Alcoholic Fatty Liver Disease Sales Market Share (2012-2017)

Table Novartis AG Basic Information List

Table Novartis AG Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis AG Non Alcoholic Fatty Liver Disease Sales Market Share (2012-2017)

Table Phenex Pharmaceuticals Basic Information List

Table Phenex Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

Table Phenex Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales Market Share (2012-2017)

Table Raptor Pharmaceuticals Basic Information List

Table Raptor Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

Table Raptor Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales Market Share (2012-2017)

Table TCM Biotech International Basic Information List

Table TCM Biotech International Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

Table TCM Biotech International Non Alcoholic Fatty Liver Disease Sales Market Share (2012-2017)

Table Tobira Therapeutics Basic Information List

Table Tobira Therapeutics Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)

Table Tobira Therapeutics Non Alcoholic Fatty Liver Disease Sales Market Share (2012-2017)

Table Verva Pharmaceuticals Basic Information List

Table Zafgen Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Non Alcoholic Fatty Liver Disease

Figure Manufacturing Process Analysis of Non Alcoholic Fatty Liver Disease

Figure Non Alcoholic Fatty Liver Disease Industrial Chain Analysis

Table Raw Materials Sources of Non Alcoholic Fatty Liver Disease Major Manufacturers in 2015

Table Major Buyers of Non Alcoholic Fatty Liver Disease

Table Distributors/Traders List

Figure Germany Non Alcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2022)

Figure Germany Non Alcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2022)

Figure France Non Alcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2022)

Figure France Non Alcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2022)

Figure UK Non Alcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2022)

Figure UK Non Alcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2022)

Figure Russia Non Alcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2022)

Figure Russia Non Alcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2022)

Figure Italy Non Alcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2022)

Figure Italy Non Alcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2022)

Figure Spain Non Alcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2022)

Figure Spain Non Alcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux Non Alcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2022)

Figure Benelux Non Alcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2022)

Table Europe Non Alcoholic Fatty Liver Disease Sales Forecast by Type (2017-2022)

Table Europe Non Alcoholic Fatty Liver Disease Sales Forecast by Application (2017-2022)